[PRNewswire] Abcam: Appointment of Vice President of Investor Relations
전체 맥락을 이해하기 위해서는 본문 보기를 권장합니다.
Michael Baldock, Chief Financial Officer of Abcam, said: "I am delighted to have Tommy joining us. His deep industry experience, significant investor relations expertise, and strong institutional investor and research analyst relationships are a major step forward for us. Tommy will be a real asset to Abcam and our investors as we continue to grow, differentiate ourselves in the marketplace, and deliver value for all our stakeholders."
본고는 자료 제공사에서 제공한 것으로, 연합뉴스는 내용에 대해 어떠한 편집도 하지 않았음을 밝혀 드립니다.
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
(CAMBRIDGE, England, June 27, 2022 PRNewswire=연합뉴스) Abcam [https://corporate.abcam.com/ ] plc ("Abcam," "Company," "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces the appointment of Tommy Thomas as Vice President of Investor Relations.
Tommy, who will be based in our Waltham, MA office, has over 20 years' experience in the life sciences sector, largely focused in the area of research tools. He joins Abcam from Avantor, where he was Vice President, Investor Relations for several years. Prior to this he was Vice President of Investor Relations, and then Chief Financial Officer of Global Services at Perkin Elmer. Before joining Perkin Elmer, Tommy spent eight years as a buy side analyst for TIAA-CREF focused on the medical technology & life science tools areas.
Michael Baldock, Chief Financial Officer of Abcam, said: "I am delighted to have Tommy joining us. His deep industry experience, significant investor relations expertise, and strong institutional investor and research analyst relationships are a major step forward for us. Tommy will be a real asset to Abcam and our investors as we continue to grow, differentiate ourselves in the marketplace, and deliver value for all our stakeholders."
Tommy Thomas commented: "I am very pleased to join Abcam at this important time in its evolution. The Company's customer-centric model focusing on new product innovation for researchers and clinicians in the life sciences industry is highly differentiated. I look forward to learning and telling our story as I build new friendships along the way."
About Abcam plc
As an innovator in reagents and tools, Abcam's purpose is to serve life science researchers globally to achieve their mission, faster. Providing the research and clinical communities with tools and scientific support, the Company offers highly validated antibodies, assays and other research tools to address important targets in critical biological pathways.
Already a pioneer in data sharing and ecommerce in the life sciences, Abcam's ambition is to be the most influential company in life sciences by helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health.
Abcam's worldwide customer base of approximately 750,000 life science researchers uses Abcam's antibodies, reagents, biomarkers and assays. By actively listening to and collaborating with these researchers, the Company continuously advances its portfolio to address their needs. A transparent programme of customer reviews and datasheets, combined with an industry-leading validation initiative, gives researchers increased confidence in their results.
Founded in 1998 and headquartered in Cambridge, UK, the Company has served customers in more than 130 countries. Abcam's ordinary shares are listed on the London Stock Exchange (AIM: ABC) and its American Depositary Shares (ADSs) trade on the Nasdaq Global Market (Nasdaq: ABCM).
Please visit corporate.abcam.com to find out more.
Logo - https://mma.prnewswire.com/media/1670705/Abcam_Logo.jpg
Abcam Logo
Source: Abcam plc
[편집자 주] 본고는 자료 제공사에서 제공한 것으로, 연합뉴스는 내용에 대해 어떠한 편집도 하지 않았음을 밝혀 드립니다.
(끝)
출처 : PRNewswire 보도자료
Copyright © 연합뉴스 보도자료. 무단전재 및 재배포 금지.
- 尹대통령-이재명 첫 회담, 29일 대통령실서 개최(종합) | 연합뉴스
- 尹대통령, 공수처장 후보에 오동운 변호사 지명 | 연합뉴스
- '빅5' 병원 교수들, 일제히 '일주일에 하루' 휴진 결정 | 연합뉴스
- 軍정신교육교재 '독도=분쟁지' 기술, 내부 문제제기 묵살됐다 | 연합뉴스
- 與, 채상병특검법에 '수사후 특검 여부 판단' 고수 | 연합뉴스
- "가정의달에 가격 올린다니"…맥도날드·피자헛 가격 인상(종합) | 연합뉴스
- '파리행 실패' 한국 U-23 축구대표팀, 27일 귀국…소속팀 복귀 | 연합뉴스
- 尹대통령 지지율, 취임후 최저치 찍은 뒤 1%p 올라 24%[한국갤럽] | 연합뉴스
- 與 차기 원내대표 후보군, 출마 저울질하며 '눈치 싸움' | 연합뉴스
- '강성 친명' 박찬대, 민주 원내대표 선거 단독 출마 | 연합뉴스